Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK2 | P49760 | 12/20 | 0.69 |
| ▸ | CLK3 | P49761 | 12/20 | 0.69 |
| ▸ | DYRK1A | Q13627 | 12/20 | 0.69 |
| ▸ | WNT1 | P04628 | 8/20 | 0.55 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19645500 | 0.92 | CLK2 (0.65) | CLK2CLK3DYRK1AWNT1 | |
| SCHEMBL17586989 | 0.90 | CLK2 (0.74) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL19263297 | 0.89 | WNT1 (0.71) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL17586977 | 0.86 | CLK2 (0.69) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL19645546 | 0.85 | CLK2 (0.61) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL19860574 | 0.85 | CLK2 (0.56) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL17586993 | 0.85 | WNT1 (0.72) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL17586987 | 0.85 | CLK2 (0.68) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL21577710 | 0.84 | WNT1 (0.60) | CLK2CLK3DYRK1AWNT1TGFBR1 | |
| SCHEMBL17586979 | 0.84 | CLK2 (0.74) | CLK2CLK3DYRK1AWNT1TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9828372-B2 | 2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof | SAMUMED, LLC (US) | 2017-11-28 | — | — | US | disclosed |